A Registry Study on HIV-related Lymphoma
Recruiting · NCT05231135 · Observational (researchers observe without assigning treatment) · Lead sponsor: Rotkreuzklinikum München gGmbH
View the official record on ClinicalTrials.gov →What this trial is about
Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Histology or cytology proven non-Hodgkin lymphoma or Hodgkin lymphoma
- HIV-infection at time of lymphoma diagnosis
- Lymphoma diagnosis since 01.01.2010
- Adult patients ≥ 18 years
- Written informed consent
Exclusion criteria
- HIV-diagnosis \> 3 months after the diagnosis of malignant lymphoma
- Non-Compliance or lack of opportunity for follow-up (for the prospective part of the study)
Where it is running
6 locations listed.
- Amsterdam University Medical Centers - Amsterdam, Netherlands
- Hospital de la Santa Creu i Sant Pau - Barcelona, Spain
- University Hospital of Wales - Cardiff, United Kingdom
- University Hospital Cologne - Cologne, Germany
- Hospital Universitario de Salamanca - Salamanca, Spain
- Red Cross Hospital Munich - Munich, Select One Option, Germany